Detalhe da pesquisa
1.
Fatty acids metabolism affects the therapeutic effect of anti-PD-1/PD-L1 in tumor immune microenvironment in clear cell renal cell carcinoma.
J Transl Med
; 21(1): 343, 2023 05 23.
Artigo
Inglês
| MEDLINE | ID: mdl-37221577
2.
CircNTNG1 inhibits renal cell carcinoma progression via HOXA5-mediated epigenetic silencing of Slug.
Mol Cancer
; 21(1): 224, 2022 12 19.
Artigo
Inglês
| MEDLINE | ID: mdl-36536414
3.
Circular RNA circSDHC serves as a sponge for miR-127-3p to promote the proliferation and metastasis of renal cell carcinoma via the CDKN3/E2F1 axis.
Mol Cancer
; 20(1): 19, 2021 01 20.
Artigo
Inglês
| MEDLINE | ID: mdl-33468140
4.
Correction: CircNTNG1 inhibits renal cell carcinoma progression via HOXA5-mediated epigenetic silencing of Slug.
Mol Cancer
; 22(1): 14, 2023 Jan 20.
Artigo
Inglês
| MEDLINE | ID: mdl-36670419
5.
Genetic risk classifier to predict localised renal cell carcinoma recurrence - Authors' reply.
Lancet Oncol
; 20(6): e288, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-31162095
6.
PABPC1L Induces IDO1 to Promote Tryptophan Metabolism and Immune Suppression in Renal Cell Carcinoma.
Cancer Res
; 84(10): 1659-1679, 2024 May 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38382068
7.
LRP1 induces anti-PD-1 resistance by modulating the DLL4-NOTCH2-CCL2 axis and redirecting M2-like macrophage polarisation in bladder cancer.
Cancer Lett
; : 216807, 2024 Mar 08.
Artigo
Inglês
| MEDLINE | ID: mdl-38462037
8.
Single-cell and spatial transcriptomics reveal 5-methylcytosine RNA methylation regulators immunologically reprograms tumor microenvironment characterizations, immunotherapy response and precision treatment of clear cell renal cell carcinoma.
Transl Oncol
; 35: 101726, 2023 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-37379773
9.
EGCG-LYS Fibrils-Mediated CircMAP2K2 Silencing Decreases the Proliferation and Metastasis Ability of Gastric Cancer Cells in Vitro and in Vivo.
Adv Sci (Weinh)
; 10(32): e2304075, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37752765
10.
Extracellular Vesicle-Mediated Transfer of LncRNA IGFL2-AS1 Confers Sunitinib Resistance in Renal Cell Carcinoma.
Cancer Res
; 83(1): 103-116, 2023 01 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36264173
11.
Exosomal circSPIRE1 mediates glycosylation of E-cadherin to suppress metastasis of renal cell carcinoma.
Oncogene
; 42(22): 1802-1820, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37046045
12.
Hsa_circ_0057105 modulates a balance of epithelial-mesenchymal transition and ferroptosis vulnerability in renal cell carcinoma.
Clin Transl Med
; 13(8): e1339, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37496319
13.
Bladder cancer intrinsic LRFN2 drives anticancer immunotherapy resistance by attenuating CD8+ T cell infiltration and functional transition.
J Immunother Cancer
; 11(10)2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37802603
14.
EHBP1L1 Drives Immune Evasion in Renal Cell Carcinoma through Binding and Stabilizing JAK1.
Adv Sci (Weinh)
; 10(11): e2206792, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36775874
15.
Identification of mRNA vaccines and conserved ferroptosis related immune landscape for individual precision treatment in bladder cancer.
J Big Data
; 9(1): 88, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35818395
16.
Chitosan-Gelatin-EGCG Nanoparticle-Meditated LncRNA TMEM44-AS1 Silencing to Activate the P53 Signaling Pathway for the Synergistic Reversal of 5-FU Resistance in Gastric Cancer.
Adv Sci (Weinh)
; 9(22): e2105077, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35717675
17.
Circular RNA circSNX6 promotes sunitinib resistance in renal cell carcinoma through the miR-1184/GPCPD1/ lysophosphatidic acid axis.
Cancer Lett
; 523: 121-134, 2021 12 28.
Artigo
Inglês
| MEDLINE | ID: mdl-34626691
18.
Positive feedback regulation of lncRNA PVT1 and HIF2α contributes to clear cell renal cell carcinoma tumorigenesis and metastasis.
Oncogene
; 40(37): 5639-5650, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34321604
19.
MRI tracking of autologous pancreatic progenitor-derived insulin-producing cells in monkeys.
Sci Rep
; 7(1): 2505, 2017 05 31.
Artigo
Inglês
| MEDLINE | ID: mdl-28566744